Excitingly, the combination of USP7 inhibitors and several current major cancer treatments has been shown to possess promising therapeutic prospects, mainly including chemotherapy, radiotherapy, and immunotherapy (such as PD-L1 treatment), which will be one of the study directions in the future. This evidence concerns the gene USP7 and cancer.